Teva Pharmaceutical Industries is a global drugmaker that develops, manufactures and markets generic medicines and a portfolio of specialty and branded pharmaceuticals.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Larry Robbins / Glenview | 61 | New buy | 7,566,877 | $299,648,329 | 4.9% |
| David Einhorn / Greenlight | 45 | New buy | 1,817,146 | $71,958,981 | 2.0% |
| Bridgewater | 55 | New buy | 982,873 | $38,921,771 | 0.2% |
| Ancora | 42 | New buy | 341 | $13,504 | 0.0% |
| Paul Tudor Jones / Tudor | 61 | New buy | 477,200 | $18,897,120 | 0.0% |
| Steve Cohen / Point72 | 75 | New buy | 345,900 | $13,697,640 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.